These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35143854)

  • 1. Concentrations of per- and polyfluoroalkyl substances (PFAS) in human placental tissues and associations with birth outcomes.
    Hall SM; Zhang S; Hoffman K; Miranda ML; Stapleton HM
    Chemosphere; 2022 May; 295():133873. PubMed ID: 35143854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse birth outcomes related to concentrations of per- and polyfluoroalkyl substances (PFAS) in maternal blood collected from pregnant women in 1960-1966.
    Zheng T; Kelsey K; Zhu C; Pennell KD; Yao Q; Manz KE; Zheng YF; Braun JM; Liu Y; Papandonatos G; Liu Q; Shi K; Brochman S; Buka SL
    Environ Res; 2024 Jan; 241():117010. PubMed ID: 37696323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of paternal and maternal per- and polyfluoroalkyl substances exposure with cord serum reproductive hormones, placental steroidogenic enzyme and birth weight.
    Yao Q; Gao Y; Zhang Y; Qin K; Liew Z; Tian Y
    Chemosphere; 2021 Dec; 285():131521. PubMed ID: 34273704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to per- and polyfluoroalkyl substances and pregnancy outcome in Austria.
    Kaiser AM; Forsthuber M; Widhalm R; Granitzer S; Weiss S; Zeisler H; Foessleitner P; Salzer H; Grasl-Kraupp B; Moshammer H; Hartmann C; Uhl M; Gundacker C
    Ecotoxicol Environ Saf; 2023 Jul; 259():115006. PubMed ID: 37182303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal per- and polyfluoroalkyl substances (PFAS) exposure in relation to preterm birth subtypes and size-for-gestational age in the LIFECODES cohort 2006-2008.
    Siwakoti RC; Cathey A; Ferguson KK; Hao W; Cantonwine DE; Mukherjee B; McElrath TF; Meeker JD
    Environ Res; 2023 Nov; 237(Pt 2):116967. PubMed ID: 37634691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal trends in perfluoroalkyl and polyfluoroalkyl substances among multiethnic midlife women from 1999 to 2011: The Study of Women's Health Across the Nation.
    Ding N; Harlow SD; Batterman S; Mukherjee B; Park SK
    Environ Int; 2020 Feb; 135():105381. PubMed ID: 31841808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Serum Perfluoroalkyl Substances and Placental Human Chorionic Gonadotropin in Early Pregnancy, Measured in the UPSIDE Study in Rochester, New York.
    Liang HW; Koistinen H; Barrett ES; Xun X; Yin Q; Kannan K; Moog NK; Ng C; O'Connor TG; Miller R; Adibi JJ
    Environ Health Perspect; 2024 Apr; 132(4):47008. PubMed ID: 38625811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program.
    Padula AM; Ning X; Bakre S; Barrett ES; Bastain T; Bennett DH; Bloom MS; Breton CV; Dunlop AL; Eick SM; Ferrara A; Fleisch A; Geiger S; Goin DE; Kannan K; Karagas MR; Korrick S; Meeker JD; Morello-Frosch R; O'Connor TG; Oken E; Robinson M; Romano ME; Schantz SL; Schmidt RJ; Starling AP; Zhu Y; Hamra GB; Woodruff TJ;
    Environ Health Perspect; 2023 Mar; 131(3):37006. PubMed ID: 36920051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort.
    Jensen RC; Glintborg D; Timmermann CAG; Nielsen F; Boye H; Madsen JB; Bilenberg N; Grandjean P; Jensen TK; Andersen MS
    Environ Res; 2022 Sep; 212(Pt D):113492. PubMed ID: 35597289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal Perfluorooctanoic Acid (PFOA) Exposure Is Associated With Lower Infant Birthweight Within the MADRES Pregnancy Cohort.
    Peterson AK; Eckel SP; Habre R; Yang T; Faham D; Farzan SF; Grubbs BH; Kannan K; Robinson M; Lerner D; Al-Marayati LA; Walker DK; Grant EG; Bastain TM; Breton CV
    Front Epidemiol; 2022; 2():934715. PubMed ID: 38455325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study.
    Yu G; Jin M; Huang Y; Aimuzi R; Zheng T; Nian M; Tian Y; Wang W; Luo Z; Shen L; Wang X; Du Q; Xu W; Zhang J;
    Environ Int; 2021 Nov; 156():106621. PubMed ID: 33984575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model.
    Bangma J; Szilagyi J; Blake BE; Plazas C; Kepper S; Fenton SE; C Fry R
    Environ Toxicol; 2020 Dec; 35(12):1395-1405. PubMed ID: 32790152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum per- and polyfluoroalkyl substance (PFAS) concentrations and predictors of exposure among pregnant African American women in the Atlanta area, Georgia.
    Chang CJ; Ryan PB; Smarr MM; Kannan K; Panuwet P; Dunlop AL; Corwin EJ; Barr DB
    Environ Res; 2021 Jul; 198():110445. PubMed ID: 33186575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach.
    Chang CJ; Barr DB; Ryan PB; Panuwet P; Smarr MM; Liu K; Kannan K; Yakimavets V; Tan Y; Ly V; Marsit CJ; Jones DP; Corwin EJ; Dunlop AL; Liang D
    Environ Int; 2022 Jan; 158():106964. PubMed ID: 34735953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.